HIF1A and hepatocellular carcinoma: Our results showed that HUVECs cultured in the supernatant of ASP-treated or HIF-1α RNAi-treated HCC cells (SK-Hep1 and Hep-3B) presented significantly reduced tubular formation capacity compared with HUVECs cultured in control HCC cell culture supernatant.